You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

SILDAFLO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sildaflo, and when can generic versions of Sildaflo launch?

Sildaflo is a drug marketed by Franklin Pharms and is included in one NDA.

The generic ingredient in SILDAFLO is silver sulfadiazine. There are twenty-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SILDAFLO?
  • What are the global sales for SILDAFLO?
  • What is Average Wholesale Price for SILDAFLO?
Summary for SILDAFLO
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 137
Patent Applications: 5,055
DailyMed Link:SILDAFLO at DailyMed
Drug patent expirations by year for SILDAFLO

US Patents and Regulatory Information for SILDAFLO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Franklin Pharms SILDAFLO silver sulfadiazine DRESSING;TOPICAL 019608-001 Nov 30, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SILDAFLO

See the table below for patents covering SILDAFLO around the world.

Country Patent Number Title Estimated Expiration
South Africa 8903986 ⤷  Sign Up
Spain 8704345 ⤷  Sign Up
Israel 73188 SYNTHETIC RESIN WOUND DRESSING ⤷  Sign Up
European Patent Office 0138740 SYNTHETIC RESIN WOUND DRESSING AND METHOD OF MANUFACTURING ⤷  Sign Up
Japan H0267215 SYNTHETIC RESIN MATRIX CONTAINING HEALING ENHANCER ⤷  Sign Up
Austria 61233 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for SILDAFLO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0350733 SPC/GB03/034 United Kingdom ⤷  Sign Up PRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.